Variant report
Variant | esv10384 |
---|---|
Chromosome Location | chr7:110484747-110485512 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs202027392 | chr7:110484750-110484751 | Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
2 | rs529776532 | chr7:110484780-110484781 | Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
3 | rs112048801 | chr7:110484787-110484788 | Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
4 | rs563311157 | chr7:110484814-110484815 | Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs368190681 | chr7:110484828-110484829 | Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs139846929 | chr7:110484879-110484880 | Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs571820062 | chr7:110484912-110484913 | Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs73419241 | chr7:110484915-110484916 | Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs189468060 | chr7:110484925-110484926 | Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs567423196 | chr7:110484935-110484936 | Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs551083522 | chr7:110484945-110484946 | Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs536396938 | chr7:110484946-110484947 | Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs2396280 | chr7:110484983-110484984 | Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs2396281 | chr7:110484999-110485000 | Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs538636124 | chr7:110485058-110485059 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs2396282 | chr7:110485124-110485125 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs566429391 | chr7:110485145-110485146 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs533793813 | chr7:110485246-110485247 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs372622599 | chr7:110485284-110485285 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs9886295 | chr7:110485288-110485289 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs541239332 | chr7:110485330-110485331 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs554760057 | chr7:110485357-110485358 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs799618 | chr7:110485378-110485379 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
24 | rs143278782 | chr7:110485440-110485441 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs369291682 | chr7:110485441-110485442 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs13222191 | chr7:110485505-110485506 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Melanoma | 18172304 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 22495311 | CNVD |
Wilms tumour | 21544195 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Low-grade fibromyxoid sarcoma | 0 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 21264507 | CNVD |
Shwachman-Diamond syndrome | 22934832 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Cutaneous malignant melanoma | 17690212 | CNVD |
Leukemia | 17361228 | CNVD |
Breast cancer | 16461572 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Malignant melanoma | 17690212 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
abortions and stillbirths | 19751515 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Lung cancer | 18438408 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 21785460 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Breast cancer | 21364760 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Prostate cancer | 16573809 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Melanoma | 17363583 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
T-cell acute lymphoblastic leukemia | 19406988 | CNVD |
Breast cancer | 16397240 | CNVD |
Biliary cancer | 19435499 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Prostate cancer | 23792589 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Autism | 19401682 | CNVD |
Non-small cell lung cancer | 19889201 | CNVD |
Acute myeloid leukemia | 18000384 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Metastatic melanoma | 18483359 | CNVD |
Autism | 18414403 | CNVD |
Autism | 19546859 | CNVD |
Schizophrenia | 19546859 | CNVD |
Tourette syndrome | 19546859 | CNVD |
Melanoma | 19188590 | CNVD |
small cell lung cancer | 20016488 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
T-cell lymphomas | 22341440 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Cancer | 20164919 | CNVD |
Breast cancer | 22522925 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
Dyslexia | 22102821 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:110480400-110486000 | Weak transcription | Fetal Stomach | stomach |
2 | chr7:110482600-110484800 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
3 | chr7:110483800-110485000 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
4 | chr7:110483800-110485000 | Weak transcription | Fetal Lung | lung |
5 | chr7:110483800-110485400 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
6 | chr7:110484000-110485800 | Enhancers | HUES6 Cell Line | embryonic stem cell |
7 | chr7:110484000-110486000 | Enhancers | HUES64 Cell Line | embryonic stem cell |
8 | chr7:110484000-110486000 | Bivalent Enhancer | iPS-18 Cell Line | embryonic stem cell |
9 | chr7:110484200-110486000 | Enhancers | HUES48 Cell Line | embryonic stem cell |
10 | chr7:110484400-110485000 | Flanking Active TSS | iPS-20b Cell Line | embryonic stem cell |
11 | chr7:110484400-110485200 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
12 | chr7:110484400-110485200 | Enhancers | H1 Cell Line | embryonic stem cell |
13 | chr7:110484400-110485400 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
14 | chr7:110484600-110485000 | Enhancers | H9 Cell Line | embryonic stem cell |
15 | chr7:110484600-110485800 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
16 | chr7:110484800-110485600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
17 | chr7:110485000-110486200 | Enhancers | Fetal Lung | lung |
18 | chr7:110485400-110485800 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |